As the leading nonproﬁt funder of psoriatic disease research in the world, NPF continues to play a key role in funding grants and fellowships aimed at various aspects of disease and comorbidities diagnosis, treatment, prevention, and cure.
NPF funded $3.28 million in 2020 and – even with the challenges of closed labs and research institutions due to the COVID-19 pandemic – $2.82 million in research fellowships and grants in 2021. In both years, research funding accounted for about one-third of all NPF expenses.
Funding of the PsA Diagnostic Test Grant was launched in 2019 and now continues into a second phase. This grant funds researchers looking to identify a reliable diagnostic tool for PsA that could reduce delays in diagnosis and thus lessen the length of time PsA goes untreated. Untreated PsA can lead to irreversible joint damage.